a month ago
ISRG
AnalystsAdam MaederAdam Maeder's Stock Forecasts
AnalystsAdam Maeder
Analyst Ranking
Top 26%
#1417 out of 5497 analysts
Average Return
+2.85%
Win Rate
50%55 out of 110
Risk vs Reward
Poor
Good
Adam Maeder's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Inspire Medical Systems IncINSP | +238.11% | $64.61 | $218.45 | 2020-04-09 - 2021-04-09 | Strong Buy |
Tactile Systems Technology IncTCMD | +149.02% | $9.16 | $22.81 | 2022-08-02 - 2023-08-01 | Strong Buy |
Inspire Medical Systems IncINSP | +96.50% | $126.85 | $249.26 | 2020-09-18 - 2021-09-17 | Strong Buy |
Nyxoah SaNYXH | +94.07% | $4.89 | $9.49 | 2023-11-09 - 2024-11-08 | Strong Buy |
Apollo Endosurgery IncAPEN | +68.40% | $4.81 | $8.10 | 2020-11-30 - 2021-11-29 | Strong Buy |
Adam Maeder Analyst Color
Get additional color on Adam Maeder's coverage of popular stocks
6 months ago
TCMD
6 months ago
EW
7 months ago
ISRG
7 months ago
EW
8 months ago
TCMD
9 months ago
INSP
10 months ago
EW
10 months ago
ISRG
a year ago
ISRG
a year ago
ABT
2 years ago
ISRG
2 years ago
ISRG
2 years ago
ISRG
2 years ago
ISRG
2 years ago
INSP
2 years ago
ISRG
2 years ago
SWAV
2 years ago
STIM
2 years ago
NYXH
3 years ago
SWAV
3 years ago
NYXH
3 years ago
ISRG
3 years ago
NSPR
3 years ago
TCMD
Adam Maeder's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Resmed IncRMD | 6 | Hold | $225.00 | -2.82% | Maintains | 17 days ago |
Nyxoah SaNYXH | 11 | Strong Buy | $6.00 | +275.00% | Reiterates | 18 days ago |
Inspire Medical Systems IncINSP | 19 | Hold | $60.00 | -3.78% | Maintains | 21 days ago |
Glaukos CorpGKOS | 2 | Strong Buy | $195.00 | +5.47% | Reiterates | 25 days ago |
Edwards Lifesciences CorpEW | 20 | Strong Buy | $101.00 | +12.48% | Reiterates | a month ago |
Intuitive Surgical IncISRG | 22 | Strong Buy | $470.00 | +24.07% | Reiterates | a month ago |
Abbott LaboratoriesABT | 7 | Strong Buy | $118.00 | +1.17% | Reiterates | a month ago |
Staar Surgical CoSTAA | 1 | Hold | $33.00 | +42.61% | Maintains | 3 months ago |
Stereotaxis IncSTXS | 3 | Strong Buy | $3.50 | +146.48% | Reiterates | 3 months ago |
Inspiremd IncNSPR | 5 | Strong Buy | $3.00 | +233.33% | Reiterates | 4 months ago |
Rxsight IncRXST | 4 | Hold | $10.00 | +60.00% | Maintains | 6 months ago |
Tactile Systems Technology IncTCMD | 6 | Strong Buy | $42.00 | +76.32% | Maintains | 6 months ago |
Sight Sciences IncSGHT | 3 | Strong Buy | $9.00 | +8.96% | Upgrades | 8 months ago |
Vicarious Surgical IncRBOT | 7 | Hold | $7.00 | N/A | Maintains | a year ago |
Nevro CorpNVRO | 15 | Hold | $5.85 | N/A | Upgrades | 2 years ago |
Inari Medical IncNARI | 7 | Hold | $80.00 | N/A | Maintains | 2 years ago |
Macy's IncM | 2 | Hold | $21.00 | N/A | Maintains | 2 years ago |
Silk Road Medical IncSILK | 6 | Hold | $20.00 | N/A | Maintains | 2 years ago |
Shockwave Medical IncSWAV | 8 | Strong Buy | $360.00 | N/A | Maintains | 2 years ago |
Neuronetics IncSTIM | 1 | Strong Buy | $8.00 | N/A | Reiterates | 2 years ago |
Axonics IncAXNX | 6 | Hold | $71.00 | N/A | Downgrades | 3 years ago |
Zynex IncZYXIQ | 2 | Strong Buy | $18.00 | N/A | Upgrades | 4 years ago |
Livanova PLCLIVN | 3 | Strong Buy | $99.00 | N/A | Maintains | 4 years ago |
Apollo Endosurgery IncAPEN | 4 | Strong Buy | $11.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.